Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danilo Perrotti

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Blood|December 18, 2007
Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemiaShujun Liu, Zhongfa Liu, Zhiliang Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2013
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemiaXiaomeng Huang, Sebastian Schwind, Bo Yu, et al.
Leukemia|September 26, 2021
Spred1 deficit promotes treatment resistance and transformation of chronic phase CMLJunjing Qiao, Chen Liang, Dandan Zhao, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 10, 2009
Modulation of DNA methylation by a sesquiterpene lactone parthenolideZhongfa Liu, Shujun Liu, Zhiliang Xie, et al.
EMBO Molecular Medicine|November 28, 2012
Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosisSahar A Saddoughi, Salih Gencer, Yuri K Peterson, et al.
The Journal of Clinical Investigation|August 25, 2007
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemiaPaolo Neviani, Ramasamy Santhanam, Joshua J Oaks, et al.
Blood|February 13, 2009
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1Ramiro Garzon, Shujun Liu, Muller Fabbri, et al.
Leukemia|February 16, 2021
Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemiaLe Xuan Truong Nguyen, Bin Zhang, Dinh Hoa Hoang, et al.
Plos One|March 16, 2007
Precancerous stem cells have the potential for both benign and malignant differentiationLi Chen, Rulong Shen, Yin Ye, et al.
Blood|April 30, 2011
Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2AArelis Salas, Suriyan Ponnusamy, Can E Senkal, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Blood|December 18, 2007
Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemiaShujun Liu, Zhongfa Liu, Zhiliang Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2013
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemiaXiaomeng Huang, Sebastian Schwind, Bo Yu, et al.
Leukemia|September 26, 2021
Spred1 deficit promotes treatment resistance and transformation of chronic phase CMLJunjing Qiao, Chen Liang, Dandan Zhao, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 10, 2009
Modulation of DNA methylation by a sesquiterpene lactone parthenolideZhongfa Liu, Shujun Liu, Zhiliang Xie, et al.
EMBO Molecular Medicine|November 28, 2012
Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosisSahar A Saddoughi, Salih Gencer, Yuri K Peterson, et al.
The Journal of Clinical Investigation|August 25, 2007
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemiaPaolo Neviani, Ramasamy Santhanam, Joshua J Oaks, et al.
Blood|February 13, 2009
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1Ramiro Garzon, Shujun Liu, Muller Fabbri, et al.
Leukemia|February 16, 2021
Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemiaLe Xuan Truong Nguyen, Bin Zhang, Dinh Hoa Hoang, et al.
Plos One|March 16, 2007
Precancerous stem cells have the potential for both benign and malignant differentiationLi Chen, Rulong Shen, Yin Ye, et al.
Blood|April 30, 2011
Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2AArelis Salas, Suriyan Ponnusamy, Can E Senkal, et al.
Pageof 9